Skip to main content
. 2022 Mar 21;15(9):1720–1726. doi: 10.1093/ckj/sfac082

Table 3.

Multivariate analyses of the determinants of humoral response assessed by protective antibody titres 1 month after each dose of vaccine

Protective level of antibodies
Month 1 Month 2
Variable OR (95% CI) P-value OR (95% CI) P-value
Age (years) 0.97 (0.95–0.99) 0.008
Haemodiafiltration (%) 1.02 (0.61–1.71) 0.93
PMMA dialysis membrane 1.03 (0.42–2.55) 0.94
Weight 1.01 (0.98–1.04) 0.42
BMI (kg/m2) 0.99 (0.91–1.07) 0.78
Smoking 0.60 (0.37–0.98) 0.04
CAD 0.78 (0.48–1.29) 0.34
Immunosuppressive drugs 1.14 (0.45–2.85) 0.78 0.37 (0.18–0.73) 0.005
Transplant 0.41 (0.18–0.92) 0.03 0.62 (0.32–1.18) 0.15
Response to HBV vaccine 1.63 (0.99–2.67) 0.06
ARB 1.75 (0.84–3.65) 0.13 1.48 (0.59–3.71) 0.40
VKA 0.48 (0.29–0.79) 0.005
Kt/V 0.84 (0.43–1.65) 0.61
Creatinine (µmol/L) 1.00 (1.00–1.00) 0.76
Calcium (mmol/L) 0.86 (0.15–5.06) 0.87
Phosphate (mmol/L) 0.61 (0.34–1.12) 0.11 0.84 (0.46–1.55) 0.58
Total protein (g/L) 1.05 (1.004–1.094) 0.03
Serum albumin (g/L) 1.02 (0.96–1.09) 0.46 1.10 (1.05–1.16) <0.001
CRP (mg/L) 1.00 (0.98–1.01) 0.67
Haemoglobin (g%) 1.13 (0.91–1.40) 0.28 1.05 (0.83–1.33) 0.66
BNT162b2 vaccine (%) 0.40 (0.24–0.64) <0.001

OR, odds ratio; CI, confidence interval.